Pulse Biosciences Stock Investor Sentiment

PLSE Stock  USD 19.66  0.08  0.41%   
About 55% of Pulse Biosciences' investor base is interested to short. The analysis of overall sentiment of trading Pulse Biosciences stock suggests that many investors are impartial at this time. The current market sentiment, together with Pulse Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Pulse Biosciences stock news signals to limit their universe of possible portfolio assets.
  
3 days ago at news.google.com         
Griffin Asset Management Inc. Has 4.14 Million Stake in Pulse Biosciences, Inc. - MarketBeat
Google News at Macroaxis
over a week ago at massdevice.com         
Pulse Biosciences is on track for IDE study of PFA tech this year
news
over a week ago at news.google.com         
Barclays PLC Grows Position in Pulse Biosciences, Inc. - MarketBeat
Google News at Macroaxis
over two weeks ago at businesswire.com         
Pulse Biosciences Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Sympo...
businesswire News
over two weeks ago at finance.yahoo.com         
Pulse Biosciences Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Sympo...
Yahoo News
over two weeks ago at businesswire.com         
Pulse Biosciences Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Sympo...
businesswire News
over two weeks ago at gurufocus.com         
Pulse Biosciences Inc Showcases Innovative nsPFA Technology at AF Symposium 2025
Gurufocus Stories at Macroaxis
over two weeks ago at massdevice.com         
Pulse Biosciences picks former Boston Scientific exec as new CEO
news
over two weeks ago at gurufocus.com         
Pulse Biosciences Inc Appoints New CEO and Announces Strategic Developments
Gurufocus Stories at Macroaxis
over two weeks ago at www.macroaxis.com         
Acquisition by Paul LaViolette of 450000 shares of Pulse Biosciences at 18.43 subject to Rule 16b-3
Macroaxis News
over three weeks ago at gurufocus.com         
Pulse Biosciences Inc to Present at J.P. Morgan Healthcare Conference
Gurufocus Stories at Macroaxis
over three weeks ago at businesswire.com         
Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference
businesswire News
over a month ago at thelincolnianonline.com         
Pulse Biosciences Shares Gap Up Should You Buy?
news
over a month ago at news.google.com         
Pulse Biosciences Triggers 66M Warrant Redemption After Stock Price Surge Above 16.50 PLSE Stock New...
Google News at Macroaxis
over a month ago at gurufocus.com         
Pulse Biosciences Inc Announces Major Shareholder Investment
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pulse Biosciences that are available to investors today. That information is available publicly through Pulse media outlets and privately through word of mouth or via Pulse internal channels. However, regardless of the origin, that massive amount of Pulse data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pulse Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pulse Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pulse Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pulse Biosciences alpha.

Pulse Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pulse Stock analysis

When running Pulse Biosciences' price analysis, check to measure Pulse Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulse Biosciences is operating at the current time. Most of Pulse Biosciences' value examination focuses on studying past and present price action to predict the probability of Pulse Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulse Biosciences' price. Additionally, you may evaluate how the addition of Pulse Biosciences to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA